16222 Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel. The 

Genes, Environment and Health Initiative. 

Date: April 27, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Vinod Charles, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6151, MSC 9606, 

Bethesda, MD 20892–9606 301–443–1606. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: April 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8012 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Continuation of a 

National Endoscopic Database. 

Date: April 29, 2009. 

Time: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact Person: Dan E. Matsumoto, PhD, 

Scientific Review Administrator, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 749, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–8894. matsumotod@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: April 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8097 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Vaccine 

Research Center Board of Scientific 

Counselors, NIAID. The meeting will be 

closed to the public as indicated below 

in accordance with the provisions set 

forth in section 552b(c)(6), Title 5 

U.S.C., as amended for the review, 

discussion, and evaluation of individual 

intramural programs and projects 

conducted by the National Institute of 

Allergy and Infectious Diseases, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Vaccine Research 

Center Board of Scientific Counselors, NIAID. 

Date: May 21–22, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Vaccine Research Center, 40 Convent Drive, 

Bethesda, MD 20892. 

Contact Person: Gary J. Nabel, MD, PhD, 

Director, Vaccine Research Center, NIAID/ 

NIH, 40 Convent Drive, Bldg. 40, Room 4502, 

Bethesda, MD 20892. 301–496–1852. 

gnabel@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: April 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8099 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The portions of the meeting devoted 

to the review and evaluation of journals 

for potential indexing by the National 

Library of Medicine will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.S.C., as 

amended. Premature disclosure of the 

titles of the journals as potential titles to 

be indexed by the National Library of 

Medicine, the discussions, and the 

presence of individuals associated with 

these publications could significantly 

frustrate the review and evaluation of 

individual journals. 

Name of Committee: Literature Selection 

Technical Review Committee. 

Date: June 18–19, 2009. 

Open: June 18, 2009, 9 a.m. to 11 a.m. 

Agenda: Administrative reports and 

program discussion. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: June 18, 2009, 11 a.m. to 5 p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: June 19, 2009, 8:30 a.m. to 2 p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: Sheldon Kotzin, MLS, 

Associate Director, Division of Library 

Operations, National Library of Medicine, 

8600 Rockville Pike, Bldg 38/Room 2W06, 


dwashington3 on PROD1PC60 with NOTICES
Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices 16223 

Bethesda, MD 20894. 301–496–6921. 

Sheldon Kotzin@nlm.nih.gov. 

Any interested person may file written 

comments with the Committee by forwarding 

the statement to the Contact Person listed on 

this Notice. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by nongovernment 

employees. Persons without a government 

I.D. will need to show a photo ID. and sign 

in at the security desk upon entering the 

building. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, I– 

IHS) 

Dated: March 31, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy, NIH. 

[FR Doc. E9–7731 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of a Meeting of a Working 

Group of the NIH Blue Ribbon Panel 

The purpose of this notice is to inform 

the public about a meeting of the NIH 

Blue Ribbon Panel to Advise on the Risk 

Assessment of the National Emerging 

Infectious Diseases Laboratories at 

Boston University Medical Center. 

The meeting will be held Tuesday, 

May 5, 2009 at the National Institutes of 

Health, Building 31, 31 Center Drive, 

Floor 6C, Room 6, Bethesda, MD 20892 

from approximately 9 a.m. to 12 p.m. 

The purpose of the meeting is for the 

Panel to review and discuss progress on 

the supplementary risk assessment 

being conducted for the Boston 

University NEIDL. The National 

Research Council Committee on 

Technical Input will participate in this 

discussion and provide its views. 

Public comment will begin at 

approximately 11:30 a.m. In the event 

that time does not allow for all those 

interested to present oral comments, 

anyone may file written comments by 

sending them to the address below. 

Comments should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the commenter. 

The meeting will be open to the 

public, with attendance limited to space 

available. There will be a live Web cast 

of the meeting which can be accessed at 

http://nihblueribbonpanel-bumcneidl.od.nih.gov/. Individuals who plan 

to attend and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. 

In the interest of security, NIH has 

instituted stringent procedures for 

entrance onto the NIH campus. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors will be asked to show 

one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

A draft agenda and slides for the 

meeting may be obtained by connecting 

to http://nihblueribbonpanel-bumcneidl.od.nih.gov/. For additional 

information concerning this meeting, 

contact Ms. Laurie Lewallen, Advisory 

Committee Coordinator, Office of 

Biotechnology Activities, Office of 

Science Policy, Office of the Director, 

National Institutes of Health, 6705 

Rockledge Drive, Room 750, Bethesda, 

MD 20892–7985; telephone 301–496– 

9838; e-mail lewallenl@od.nih.gov. 

Dated: April 2, 2009. 

Amy P. Patterson, 

Acting Director, Office of Science Policy, 

National Institutes of Health. 

[FR Doc. E9–8009 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Fiscal Year (FY) 2009 Funding 

Opportunity 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice of intent to award a 

Single Source Grant to Case 

Management, Inc. (CMI), Memphis, TN. 

SUMMARY: This notice is to inform the 

public that the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) intends to award 

approximately $500,000 (total costs) per 

year for up to two years to Case 

Management, Inc. (CMI), Memphis, TN. 

This is not a formal request for 

applications. Assistance will be 

provided only to Case Management, Inc. 

(CMI) based on the receipt of a 

satisfactory application that is approved 

by an independent review group. 

Funding Opportunity Title: Services 

Grant Program for Residential Treatment 

for Pregnant and Postpartum Women— 

Babylove II; TI–09–009. 

Catalog of Federal Domestic 

Assistance (CFDA) Number: 93.243. 

Authority: Section 508 of the Public Health 

Service Act, as amended. 

Justification: Only Case Management, 

Inc. (CMI) is eligible to apply. The 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) is 

seeking to award a single source grant 

to Case Management, Inc. (CMI) to carry 

out the remainder of the CSAT-funded 

FY 2008 PPW Babylove II Project. 

Midtown Mental Health Center 

(MMHC), the recipient of an FY 2008 

CSAT PPW grant award, notified 

SAMHSA that it: had ceased business; 

had been recently acquired by Case 

Management, Inc. (CMI); and transferred 

its contacts and patients to CMI effective 

September 16, 2008. Furthermore, CMI 

had assumed all of MMHC’s existing 

obligations under patient care contracts 

and/or grants. This transfer included 

relinquishing the FY 2008 CSAT PPW 

grant award issued on September 1, 

2008, and transferring all associated 

patient services provided by the 

SAMHSA/CSAT grant-funded Babylove 

II Program. 

The Babylove II PPW Project is 

currently the only program in West 

Tennessee that provides specialized 

long-term residential treatment services 

for pregnant and postpartum women 

with co-occurring disorders, where the 

children can reside in the residential 

treatment facility with their mothers. 

CMI has been approved by SAMHSA/ 

CSAT Grants Management as the 

replacement grantee for the remainder 

of the current budget period (12/16/08– 

9/29/09). According to the Awarding 

Agency Grants Administration Manual 

(AAGAM), as a replacement grantee, 

CMI is not automatically approved for 

the future budget years (i.e., years 2 and 

3). This sole source grant will cover the 

future budget years of this 3 year grant 

program. 

Contact: Shelly Hara, Substance 

Abuse and Mental Health Services 

Administration, 1 Choke Cherry Road, 

Room 8–1081, Rockville, MD 20857; 

telephone: (240) 276–2321; e-mail: 

shelly.hara@samhsa.hhs.gov. 

Toian Vaughn, 

SAMHSA Committee Management Officer. 

[FR Doc. E9–8053 Filed 4–8–09; 8:45 am] 

BILLING CODE 4162–20–P 


dwashington3 on PROD1PC60 with NOTICES